These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9009672)

  • 1. Adipocyte differentiation is regulated by a prostaglandin liganded to the nuclear peroxisome proliferator-activated receptor.
    Wolf G
    Nutr Rev; 1996 Sep; 54(9):290-2. PubMed ID: 9009672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation.
    Kliewer SA; Lenhard JM; Willson TM; Patel I; Morris DC; Lehmann JM
    Cell; 1995 Dec; 83(5):813-9. PubMed ID: 8521498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma.
    Forman BM; Tontonoz P; Chen J; Brun RP; Spiegelman BM; Evans RM
    Cell; 1995 Dec; 83(5):803-12. PubMed ID: 8521497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes.
    Mukherjee R; Hoener PA; Jow L; Bilakovics J; Klausing K; Mais DE; Faulkner A; Croston GE; Paterniti JR
    Mol Endocrinol; 2000 Sep; 14(9):1425-33. PubMed ID: 10976920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of ligands for the nuclear peroxisome proliferator-activated receptors.
    Willson TM; Lehmann JM; Kliewer SA
    Ann N Y Acad Sci; 1996 Dec; 804():276-83. PubMed ID: 8993550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adipocyte differentiation and nuclear receptor].
    Hirose T; Kurebayashi S
    Nihon Rinsho; 1997 Jun; 55(6):1596-604. PubMed ID: 9200953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor-gamma represses GLUT4 promoter activity in primary adipocytes, and rosiglitazone alleviates this effect.
    Armoni M; Kritz N; Harel C; Bar-Yoseph F; Chen H; Quon MJ; Karnieli E
    J Biol Chem; 2003 Aug; 278(33):30614-23. PubMed ID: 12777391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiazolidinedione induces the adipose differentiation of fibroblast-like cells resident within bovine skeletal muscle.
    Torii SI; Kawada T; Matsuda K; Matsui T; Ishihara T; Yano H
    Cell Biol Int; 1998; 22(6):421-7. PubMed ID: 10328850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation.
    Oberfield JL; Collins JL; Holmes CP; Goreham DM; Cooper JP; Cobb JE; Lenhard JM; Hull-Ryde EA; Mohr CP; Blanchard SG; Parks DJ; Moore LB; Lehmann JM; Plunket K; Miller AB; Milburn MV; Kliewer SA; Willson TM
    Proc Natl Acad Sci U S A; 1999 May; 96(11):6102-6. PubMed ID: 10339548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptors, orphans with ligands and functions.
    Schoonjans K; Martin G; Staels B; Auwerx J
    Curr Opin Lipidol; 1997 Jun; 8(3):159-66. PubMed ID: 9211064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma).
    Lehmann JM; Moore LB; Smith-Oliver TA; Wilkison WO; Willson TM; Kliewer SA
    J Biol Chem; 1995 Jun; 270(22):12953-6. PubMed ID: 7768881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel genes regulated by the insulin sensitizer rosiglitazone during adipocyte differentiation.
    Albrektsen T; Frederiksen KS; Holmes WE; Boel E; Taylor K; Fleckner J
    Diabetes; 2002 Apr; 51(4):1042-51. PubMed ID: 11916924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current topics in the regulation of prostanoids--4. The feedback regulation by PPAR-gamma].
    Ohara M; Sawa T
    Masui; 1999 Feb; 48(2):146-51. PubMed ID: 10087822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profile of adipocyte differentiation and its regulation by peroxisome proliferator-activated receptor-gamma agonists.
    Gerhold DL; Liu F; Jiang G; Li Z; Xu J; Lu M; Sachs JR; Bagchi A; Fridman A; Holder DJ; Doebber TW; Berger J; Elbrecht A; Moller DE; Zhang BB
    Endocrinology; 2002 Jun; 143(6):2106-18. PubMed ID: 12021175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the nuclear receptor peroxisome proliferator-activated receptor gamma promotes brown adipocyte differentiation.
    Tai TA; Jennermann C; Brown KK; Oliver BB; MacGinnitie MA; Wilkison WO; Brown HR; Lehmann JM; Kliewer SA; Morris DC; Graves RA
    J Biol Chem; 1996 Nov; 271(47):29909-14. PubMed ID: 8939934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone.
    Camp HS; Li O; Wise SC; Hong YH; Frankowski CL; Shen X; Vanbogelen R; Leff T
    Diabetes; 2000 Apr; 49(4):539-47. PubMed ID: 10871190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peroxisome proliferator-activated receptor(PPAR)--structure, function, tissue distribution, gene expression].
    Takeyama K; Kodera Y; Suzawa M; Kato S
    Nihon Rinsho; 2000 Feb; 58(2):357-63. PubMed ID: 10707558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor-gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells.
    Gimble JM; Robinson CE; Wu X; Kelly KA; Rodriguez BR; Kliewer SA; Lehmann JM; Morris DC
    Mol Pharmacol; 1996 Nov; 50(5):1087-94. PubMed ID: 8913339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation.
    Schoonjans K; Staels B; Auwerx J
    Biochim Biophys Acta; 1996 Jul; 1302(2):93-109. PubMed ID: 8695669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity.
    Rieusset J; Touri F; Michalik L; Escher P; Desvergne B; Niesor E; Wahli W
    Mol Endocrinol; 2002 Nov; 16(11):2628-44. PubMed ID: 12403851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.